This trial is active, not recruiting.

Condition lung cancer
Start date January 2010
End date July 2016
Trial size 2500 participants
Trial identifier NCT01192919, IOM TLK


Overview of actually used therapy forms in patients with bronchial carcinoma requiring treatment.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Patients with lung cancer requiring therapy

Primary Outcomes

Documentation of actually used therapy forms in bronchial carcinoma requiring treatment
time frame: 3 years per patient

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - all patients suffering from Small Cell Lung Cancer (SCLC), Non Small Lung Cancer (NSCLC) or neuroendocrine tumors receiving therapy

Additional Information

Official title Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.
Principal investigator Hans-Werner Tessen, MD
Trial information was received from ClinicalTrials.gov and was last updated in June 2016.
Information provided to ClinicalTrials.gov by iOMEDICO AG.